OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2021
(4)
2022
(2)
2024
(1)
2020
(1)
2019
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia.
Not available
S-EPMC10205601
|
biostudies-literature
Cite
Bi-allelic Loss-of-Function CACNA1B Mutations in Progressive Epilepsy-Dyskinesia.
Not available
S-EPMC6507039
|
biostudies-literature
Cite
Prone Positioning and Survival in Mechanically Ventilated Patients With Coronavirus Disease 2019-Related Respiratory Failure.
Not available
S-EPMC8277560
|
biostudies-literature
Cite
In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study.
Not available
S-EPMC7525342
|
biostudies-literature
Cite
Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19.
Not available
S-EPMC7863679
|
biostudies-literature
Cite
Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial.
Not available
S-EPMC11658795
|
biostudies-literature
Cite
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19.
Not available
S-EPMC7577201
|
biostudies-literature
Cite
Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19.
Not available
S-EPMC9575399
|
biostudies-literature
Cite
AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19.
Not available
S-EPMC7894677
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets